Patients with locally advanced gastric cancers saw complete response rates of 18.3% from camrelizumab and rivoceranib plus ...

CAN-2409 resulted in disease-free survival improvements for patients with high-risk, localized prostate cancer.

Tecentriq plus chemotherapy did not improve event-free survival in triple-negative breast cancer but increased rate of ...

Unloxcyt was approved by the FDA as a new treatment for patients with locally advanced or metastatic cutaneous squamous cell ...

Several biomarkers may predict improved treatment responses and outcomes in patients with triple-negative breast cancer.

As a survivor of MDS, I’ve learned to make the best of every day and to be thankful for life. Sometimes this means avoiding ...

From Gerry Turner announcing he has cancer to the return of a Chicago Cubs legend’s disease, here’s what’s happening in the ...

For many years, I have trained my mind to have more discipline, especially after being diagnosed with testicular cancer in my ...

Detections of ctDNA at baseline in patients with HR-positive early breast cancer were associated with larger tumor size.

Patients with early breast cancer who are older may experience high-grade immune-related side effects after receiving immune ...

Gratitude is actively practiced, even amidst personal losses and living with metastatic cancer, highlighting its importance ...

Experts discussed what other information is needed to understand how best to use Kisqali in treating patients in the adjuvant ...